Moore Capital Management LP Acquires 30,255 Shares of Teleflex Incorporated $TFX

Moore Capital Management LP lifted its holdings in Teleflex Incorporated (NYSE:TFX) by 29.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 134,686 shares of the medical technology company’s stock after acquiring an additional 30,255 shares during the period. Moore Capital Management LP owned 0.30% of Teleflex worth $16,437,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in TFX. Empowered Funds LLC lifted its holdings in shares of Teleflex by 15.8% in the 1st quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock valued at $233,000 after acquiring an additional 230 shares during the last quarter. Jane Street Group LLC lifted its stake in Teleflex by 42.6% in the first quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock worth $877,000 after purchasing an additional 1,895 shares during the last quarter. American Century Companies Inc. lifted its stake in Teleflex by 32.7% in the second quarter. American Century Companies Inc. now owns 13,640 shares of the medical technology company’s stock worth $1,614,000 after purchasing an additional 3,360 shares during the last quarter. Invesco Ltd. lifted its stake in Teleflex by 1.2% in the second quarter. Invesco Ltd. now owns 135,516 shares of the medical technology company’s stock worth $16,040,000 after purchasing an additional 1,659 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its stake in Teleflex by 108.1% in the second quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock worth $119,000 after purchasing an additional 521 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Truist Financial reissued a “hold” rating and issued a $143.00 price objective (up from $135.00) on shares of Teleflex in a research note on Monday, May 11th. Bank of America raised shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price objective for the company in a research note on Monday, April 13th. Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and raised their price objective for the stock from $135.00 to $155.00 in a research note on Friday, May 8th. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research note on Friday, March 27th. Finally, Raymond James Financial reissued an “outperform” rating and issued a $150.00 price objective on shares of Teleflex in a research note on Friday, May 8th. Four investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Teleflex has a consensus rating of “Hold” and an average price target of $146.00.

Teleflex Stock Performance

Shares of NYSE:TFX opened at $125.08 on Thursday. The firm has a market cap of $5.54 billion, a PE ratio of -5.49, a price-to-earnings-growth ratio of 0.95 and a beta of 0.82. The firm’s 50 day simple moving average is $129.31 and its 200-day simple moving average is $119.24. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55. Teleflex Incorporated has a one year low of $100.18 and a one year high of $139.67.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.18. The company had revenue of $548.30 million for the quarter, compared to analyst estimates of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. Teleflex’s revenue was up 32.3% compared to the same quarter last year. During the same period last year, the company posted $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities analysts predict that Teleflex Incorporated will post 6.7 EPS for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, May 25th will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Friday, May 22nd. Teleflex’s dividend payout ratio (DPR) is presently -5.96%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.